Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Neuroendocrine Tumors 18Pituitary Neoplasms 5Pheochromocytoma 3Insulinoma 3Thyroid Carcinoma, Anaplastic 2Pituitary ACTH Hypersecretion 2Paraganglioma 2Neuroblastoma 2Multiple Endocrine Neoplasia Type 1 2Meningioma 2Lung Neoplasms 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Carcinoid Tumor 2Breast Neoplasms 2Adrenocortical Carcinoma 2Adrenal Gland Neoplasms 2von Hippel-Lindau Disease 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Thyroid cancer, medullary 1Thyroid Cancer, Papillary 1Sexual Infantilism 1Serotonin Syndrome 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroma, Acoustic 1

Interventions

Liraglutide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Sexual Infantilism × Endocrine × Clear all
NCT06217848 2024-01-23

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

Seoul National University Hospital

Phase EARLY_PHASE1 Unknown
50 enrolled
CNSEndocrine

Combined Pituitary Hormone Deficiency, Craniopharyngioma, Sexual Infantilism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡